Gaudium IVF IPO
Market Sentiment
Market Lot Size
IPO Details
IPO Reservation
Financial Analysis
| Metric | 2023 | 2024 | 2025 |
|---|---|---|---|
| Revenue | 44.26 | 48.15 | 70.96 |
| Expense | 25.95 | 31.52 | 45.54 |
| Profit (PAT) | 13.53 | 10.32 | 19.13 |
| Total Assets | 36.63 | 51.01 | 88.51 |
Promoters: Dr. Manika Khanna, Dr. Peeyush Khanna and Vishad Khanna
| Shareholding | No. of Shares | Holding % |
|---|---|---|
| Promoter Holding Pre Issue | 6,13,94,384 | 99.99% |
| Promoter Holding Post Issue | 7,27,86,884 | 71.30% |
Company Information
Gaudium IVF, founded in March 2015, is one of the leading companies offering In Vitro Fertilization (IVF) treatments for women across India. The company operates its business over 30 locations, with seven hubs (centres) and twenty-eight spokes. The firm treats its patients in various countries, including Canada, the United Kingdom, the United States, Kenya, South Africa, and Oman. The firm offers various fertility services such as Vitro Fertilisation (IVF), intracytoplasmic sperm injection (ICSI), intrauterine insemination (IUI), and ovulation induction. Its treatments are targeted towards both genders. Moreover, the firm also provides PCOD/PCOS, endometriosis, and special care for women in pregnancy with complex fertility issues. Gaudium IVF also offers treatments targeting male infertility, including advanced sperm retrieval procedures.
| Purpose | Amount (Cr) |
|---|---|
| Funding capital expenditure towards establishment of New IVF Centers of the Company | 50.00 |
| Repayment/pre-payment, in full or in part, of certain outstanding loans availed by our Company; and | 20.00 |
| General Corporate Purpose | - |
Resources & Documents
Gaudium IVF & Women’s Health Ltd., B1/51,, Janak Puri,, B-1,, New Delhi, New Delhi, 110058
Gaudium IVF has set a price band of Rs 75–Rs 79 per share for an issue size of Rs 165 crore. The stock listed with a 5.06% gain versus its issue price on February 27, 2026.
Gaudium IVF, founded in March 2015, is one of the leading companies offering In Vitro Fertilization (IVF) treatments for women across India. The company operates its business over 30 locations, with seven hubs (centres) and twenty-eight spokes.
The issue is promoted by Dr. Manika Khanna, Dr. Peeyush Khanna and Vishad Khanna with Sarthi Capital Advisors Pvt. Ltd. acting as lead manager. Net proceeds will primarily be used towards Funding capital expenditure towards establishment of New IVF Centers of the Company (Rs 50 crore) and Repayment/pre-payment, in full or in part, of certain outstanding loans availed by our Company; and (Rs 20 crore).
Grey market is quoting a discount of Rs -4 (-5.1% over issue price), down Rs 4 from the previous session. Final subscription data records overall subscription at 7.27x, retail at 7.60x, QIB at 1.62x, NII at 14.05x.
On fundamentals, the company is posting revenue growth of 47.4%, a profit margin of 27.0%, return on equity of 41.3% in its most recent reported period.
Our data-driven engine currently flags this issue as a Neutral stance — the data is mixed and the risk-reward is balanced rather than one-sided. Past performance does not predict future returns — review the price chart and peer comparison below before trading.
Understanding Grey Market Premium (GMP)
The Grey Market Premium (GMP) is an unofficial indicator of how an IPO's shares are trading in the grey market before they are officially listed on a stock exchange. It reflects investor sentiment and demand for the IPO shares ahead of listing day.
How does it work? The grey market is an informal, over-the-counter market where investors buy and sell IPO shares before the official listing date. If an IPO has a positive GMP, it suggests that investors expect the stock to list above its issue price. A negative GMP indicates expectations of a listing below the issue price.
Example: If an IPO has an issue price of ₹100 and the GMP is ₹50, the expected listing price would be approximately ₹150 (issue price + GMP). This translates to an estimated listing gain of 50%.
Factors that influence GMP:
- Subscription levels — Higher subscription typically drives GMP up
- Market conditions — Bullish markets tend to boost GMP across all IPOs
- Company fundamentals — Strong financials and growth potential attract premium
- Industry sentiment — Positive outlook for the sector can increase demand
- IPO pricing — Reasonably priced IPOs relative to peers tend to command higher GMP
Disclaimer: GMP is an unofficial metric from the grey market and is not regulated by SEBI or any stock exchange. GMP values fluctuate frequently and should not be the sole basis for investment decisions. Always consider company fundamentals, financial health, and your own risk appetite before investing in any IPO.
Related IPO
No comments yet. Be the first to share your opinion!